jueves, octubre 1, 2026
InicioEstheticianWhat You Must Know

What You Must Know


Pancreatic most cancers, which impacts about 60,000 Individuals yearly, is among the deadliest types of most cancers. After analysis, fewer than 10 % of sufferers survive for 5 years.

Whereas some chemotherapies are initially efficient, pancreatic tumors usually turn out to be proof against them. The illness has additionally confirmed troublesome to deal with with newer approaches similar to immunotherapy.

Dr Steve Bigelsen 

Steve Bigelsen, MD is a doctor specializing in Allergy and Bronchial asthma, who in July 2016 was identified with pancreatic adenocarcinoma. He had tumors within the head and the tail with scattered peritoneal metastases and a CA19-9 of 11,575 U/ml. Working with physicians from Weill-Cornell and Johns Hopkins, he started remedy with gemcitabine and capecitabine, plus IV paricalcitol (an analog of Vitamin D) and hydroxychloroquine (an previous malaria drug). Each of those are in scientific trials individually, nevertheless, nobody had ever mixed them. Each are comparatively protected, cheap, and could also be prescribed by any oncologist as they’re already available on the market for different circumstances. He has now loved an entire response along with his newest CA19-9 of simply 18 U/ml and no proof of energetic illness for the previous 2 years.

As a doctor who doesn’t apply various or complementary therapies, he’s conscious of the hurdles and arguments in opposition to recommending non-FDA accepted therapies and has a number of issues himself. He believes that if these issues are adequately addressed, we are able to fill a void that’s sorely missing between sufferers in search of one thing experimental to enhance their odds of survival (a lot of whom flip to inappropriate, futile various therapies) and the respectable scientific neighborhood who has actual hope to supply.

Pancreatic Most cancers and CA19-9 Tumor Marker Ranges

The graph beneath shows the take a look at outcomes of a Stage 4 Pancreatic Most cancers affected person’s tumor marker ranges over time.  

http://whsc.emory.edu/analysis/morningside/2019-conference-bios.html

The decrease the CA19-9, usually, the decrease the most cancers exercise. Inside days of including a repurposed drug cocktail to straightforward remedy, this affected person’s CA19-9 degree dropped like a stone, sooner than any of his Oncologists had seen with any such most cancers. The repurposed medication he added had been Hydroxychloroquine and Paricalcitol – a type of injectable Vitamin D.

A traditional CA19-9 degree in somebody with out most cancers is beneath 35. This affected person with terminal Pancreatic most cancers noticed his ranges drop from 11,500 to beneath 35 in about three months. Nonetheless, he was not a mean affected person; he was himself a doctor. 

Dr. Stephen Bigelsen has taught at Rutgers College Medical College as a professor in Allergy and Immunology. He’s a scientist and goes by the guide. He researched his most cancers and spoke to others who did extra particular analysis, and he didn’t settle for the consensus customary of care. As a substitute, he innovated, and he stays alive, some 5 years later, absolutely recovered from Pancreatic Most cancers. Like Ivermectin, Hydroxychloroquine and Paricalcitol are repurposed medication. They’re deemed protected and efficient by the FDA for one more illness, but utilized in most cancers after displaying scientific promise. 

Like Ivermectin, the FDA and regulators hate the thought of repurposed medication as a result of they’re getting used with out their permission or approval. Regardless, it’s authorized for physicians to prescribe them in the event that they consider, primarily based upon their data and expertise, it could assist and even save a life. Within the case of Dr. Bigelsen, it was his personal life that was saved.

QUESTIONS:

#1. Suppose nobody survives Stage 4 Pancreatic Most cancers utilizing customary remedy – the usual remedy of chemo/radiation/surgical procedure obtained by Alex Trebek, Patrick Swayze, and Michael Landon. Why do not we INFORM ALL most cancers sufferers that repurposed medication are an choice? Should you be a doctor like Dr. Stephen Bigelsen to get the repurposed cocktail? Most of us would by no means know even to ask.

https://overcoming-together.com/dr-stephen-bigelsen-charts-his-own-course-to-overcome-stage-iv-pancreatic-cancer/

Should a affected person come across a guide that explains this?

https://amzn.to/3jPLU3p

Only a few individuals come upon repurposed medication for most cancers. Because of this, 99.999% by no means get the kind of remedy that Dr. Bigelsen did. And he tells his story that getting right into a scientific trial will not be all that useful for those who get just one drug, or solely get the placebo, or for those who wait till the late phases when most cancers has returned in a resistant state.

Getting right into a scientific trial in any case else fails in most cancers care is just too little, too late. It could assist the research, nevertheless it normally does little for the affected person. Dr. Bigelsen acquired all of the medication began by writing a prescription for himself, one thing most of us can not do.

The repurposed drug cocktails MUST BE STARTED EARLY.

It’s the similar with COVID-19. The sooner one begins the Ivermectin, the higher. In India, complete households would start the Ivermectin the second one member of the family acquired sick. This technique proved remarkably efficient, and it didn’t produce deaths, strokes, or blood clots.

What’s the level of all this? 1.9 million Individuals contract most cancers annually, and 600,000 die from the illness. These numbers, in my view, will be diminished by 1/3 by the widespread adoption of repurposed drug cocktails. Sadly, the usual of care for many cancers stays Chemo/Radiation/Surgical procedure. I write so much in regards to the SAM cocktail, a mixture of Statin/Aspirin/Metformin. Dr. Bigelsen writes about this as effectively.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6049054

READ MORE: https://www.thedesertreview.com/opinion/columnists/how-are-cancer-viruses-and-vaccines-related-hint-ivermectin/article_fa43ba8a-e365-11eb-8bf8-8f0c56cbf874.html

Does hydroxychloroquine kill most cancers?

A 2017 overview — which reviewed greater than 190 research investigating how chloroquine (CQ) and hydroxychloroquine (HCQ) have an effect on most cancers cells — describes how the malaria medication might improve tumor sensitivity to present most cancers therapies.

Primarily based on their findings, first research writer Ciska Verbaanderd, from the College of Leuven in Belgium, and her colleagues say that the medication “deserve additional scientific investigations in a number of most cancers sorts.”

The overviewTrusted Supply was printed within the journal ecancermedicalscience.

Whereas america has seen a fall in most cancers loss of life charges lately, the illness stays a big burden on public well being. Final 12 months, there have been greater than 1.6 millionTrusted Supply new most cancers circumstances identified within the U.S. and greater than 595,000 most cancers deaths.

On condition that most cancers is more and more changing into proof against present therapies, there’s a determined have to uncover new methods to combat the illness.

Verbaanderd and colleagues consider that the medication CQ and HCQ may assist on this combat.

CQ and HCQ as most cancers therapies

CQ and HCQ are drugs used to forestall and deal with malaria. They might even be used within the remedy of lupus and rheumatoid arthritis. A wealth of analysisTrusted Supply, nevertheless, has instructed that these medication may have anti-cancer properties.

For his or her overview, Verbaanderd and colleagues analyzed the outcomes of greater than 190 animal and human research that assessed the consequences of CQ and HCQ on various kinds of most cancers.

Based on the researchers, the intention of their overview was “to tell additional analysis and trials on repurposing CQ and HCQ as anti-cancer brokers.”

The group uncovered proof to counsel that CQ and HCQ could possibly be efficient for the remedy of numerous cancers, together with glioblastoma — which is a lethal mind most cancers — lung most cancers, and pancreatic most cancers.

“CQ and HCQ have been studied in a number of preclinical most cancers fashions,” write the authors, “and have demonstrated exercise on a number of cancer-supporting pathways and together with a broad vary of different therapies.”

“[…] Nearly all of these research have reported an improved therapeutic efficacy as in contrast with monotherapy with present anti-cancer medication,” they add.

The overview additionally signifies that each medication are “protected and tolerable” as an anti-cancer remedy, although present proof means that HCQ may pose fewer unwanted effects.

How can CQ and HCQ combat most cancers?

Based on the group, their overview highlights numerous mechanisms by which CQ and HCQ may assist to deal with most cancers.

Firstly, there’s proof to counsel that the medication can inhibit autophagy, which is the method whereby cells devour their very own broken or pointless parts.

“Autophagic properties similar to nutrient recycling can help most cancers cell survival,” the authors notice. “Furthermore, key regulators of cell progress will be degraded and the DNA injury response will be suppressed by way of elevated autophagy.”

“Subsequently, inhibition of autophagy will be an attention-grabbing anti-cancer technique when most cancers cells begin relying on autophagy for survival.”

The overview additionally revealed that CQ and HCQ can block the CXCL12/CXCR4 signaling pathway, which earlier analysis has related to most cancers development.

Moreover, there’s proof that CQ can stabilize a protein referred to as p53, which is a recognized tumor suppressor, and it could additionally assist to normalize blood vessel dysfunction in tumors.

“The advantages of vessel normalization embody a lower in tumor hypoxia, diminished most cancers cell intravasation and metastasis, and a rise in chemotherapeutic drug supply and response,” the authors clarify.

Medicine may provide ‘vital scientific profit’

Total, Verbaanderd and colleagues consider that their research has highlighted the potential advantages of CQ and HCQ as a most cancers remedy, in addition to the mechanisms behind their anti-cancer properties.

The group notes that there are 30 scientific trials at present investigating the consequences of CQ and HCQ in opposition to varied most cancers sorts.

Primarily based on their overview, the researchers conclude that these trials ought to concentrate on the efficacy of those drugs, in addition to the most effective doses and strategies of administration.

RELATED ARTICLES

DEJA UNA RESPUESTA

Por favor ingrese su comentario!
Por favor ingrese su nombre aquí

Most Popular

Recent Comments

Esta web utiliza cookies propias para su correcto funcionamiento. Al hacer clic en el botón Aceptar, acepta el uso de estas tecnologías y el procesamiento de tus datos para estos propósitos. Más información
Privacidad